Maxinutrition in £162 million sale
Pharmaceuticals giant GlaxoSmithKline is to acquire the nutritional products business Maxinutrition Group from Darwin Private Equity for £162 million.
News
Pharmaceuticals giant GlaxoSmithKline is to acquire the nutritional products business Maxinutrition Group from Darwin Private Equity for £162 million.
News
News
Partner content
Accounting and Finance Software
Accounting and Finance Software